Literature DB >> 8215404

Dimer- and oligomerization of the erythropoietin receptor by disulfide bond formation and significance of the region near the WSXWS motif in intracellular transport.

O Miura1, J N Ihle.   

Abstract

The receptor for erythropoietin (EpoR), a primary regulator of erythropoiesis, belongs to the cytokine receptor family. Although the mechanisms of signal transduction through the receptors of this family are largely unknown, increasing numbers of the receptors have been shown to form a hetero- or homodimer. To address the possibility that the EpoR dimerizes, we made a truncated mutant receptor that lacks most of the cytoplasmic domain and expressed it either alone or with the wild-type receptor in an IL-3-dependent cell line, DA-3. Dimerization of the receptor was demonstrated by a coimmunoprecipitation using an antiserum against the cytoplasmic domain of the receptor. Epo stimulation did not have a detectable effect on dimerization. Coimmunoprecipitation experiments in COS-7 cells further revealed that only the extracellular domain of the receptor is required for dimerization. The "WSXWS" motif, conserved in the cytokine receptor family, was shown to not be required for dimerization. Diagonal two-dimensional gel analysis of the EpoR expressed in DA-3 transfectants showed that a substantial portion of the receptor forms dimers or oligomers with disulfide bonds. Western blot analysis, using an antiphosphotyrosine antibody, revealed that a portion of these dimers or oligomers become tyrosine phosphorylated after Epo stimulation, thus suggesting that these forms are expressed on the cell surface and activated by Epo stimulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215404     DOI: 10.1006/abbi.1993.1501

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Macromolecular docking of a three-body system: the recognition of human growth hormone by its receptor.

Authors:  D K Hendrix; T E Klein; I D Kuntz; T E Klien
Journal:  Protein Sci       Date:  1999-05       Impact factor: 6.725

2.  Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function.

Authors:  Stéphane Pelletier; Sébastien Gingras; Megumi Funakoshi-Tago; Sherié Howell; James N Ihle
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

3.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

4.  LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation.

Authors:  Jing Ai; Lawrence J Druhan; Melissa G Hunter; Megan J Loveland; Belinda R Avalos
Journal:  J Leukoc Biol       Date:  2008-02-13       Impact factor: 4.962

5.  A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation.

Authors:  D L Barber; J C DeMartino; M O Showers; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

Review 6.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

7.  EPO does not promote interaction between the erythropoietin and beta-common receptors.

Authors:  Karen S Cheung Tung Shing; Sophie E Broughton; Tracy L Nero; Kevin Gillinder; Melissa D Ilsley; Hayley Ramshaw; Angel F Lopez; Michael D W Griffin; Michael W Parker; Andrew C Perkins; Urmi Dhagat
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.